212 related articles for article (PubMed ID: 14581669)
1. Huntington's disease: clinical correlates of disability and progression.
Mahant N; McCusker EA; Byth K; Graham S;
Neurology; 2003 Oct; 61(8):1085-92. PubMed ID: 14581669
[TBL] [Abstract][Full Text] [Related]
2. Dystonia-predominant adult-onset Huntington disease: association between motor phenotype and age of onset in adults.
Louis ED; Anderson KE; Moskowitz C; Thorne DZ; Marder K
Arch Neurol; 2000 Sep; 57(9):1326-30. PubMed ID: 10987900
[TBL] [Abstract][Full Text] [Related]
3. Rate and correlates of weight change in Huntington's disease.
Hamilton JM; Wolfson T; Peavy GM; Jacobson MW; Corey-Bloom J;
J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):209-12. PubMed ID: 14742590
[TBL] [Abstract][Full Text] [Related]
4. A clinical study of patients with genetically confirmed Huntington's disease from India.
Murgod UA; Saleem Q; Anand A; Brahmachari SK; Jain S; Muthane UB
J Neurol Sci; 2001 Sep; 190(1-2):73-8. PubMed ID: 11574110
[TBL] [Abstract][Full Text] [Related]
5. Clinical characterization of dystonia in adult patients with Huntington's disease.
van de Zande NA; Massey TH; McLauchlan D; Pryce Roberts A; Zutt R; Wardle M; Payne GC; Clenaghan C; Tijssen MAJ; Rosser AE; Peall KJ
Eur J Neurol; 2017 Sep; 24(9):1140-1147. PubMed ID: 28661018
[TBL] [Abstract][Full Text] [Related]
6. Clinical and genetic characteristics of late-onset Huntington's disease.
Oosterloo M; Bijlsma EK; van Kuijk SM; Minkels F; de Die-Smulders CE
Parkinsonism Relat Disord; 2019 Apr; 61():101-105. PubMed ID: 30528461
[TBL] [Abstract][Full Text] [Related]
7. Adult-onset Huntington's disease that presented without chorea.
Iwata A; Ishihara K; Tsuji S
Intern Med; 2013; 52(18):2121-2. PubMed ID: 24042524
[TBL] [Abstract][Full Text] [Related]
8. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
[TBL] [Abstract][Full Text] [Related]
9. Atypical movement disorders in the early stages of Huntington's disease: clinical and genetic analysis.
Squitieri F; Berardelli A; Nargi E; Castellotti B; Mariotti C; Cannella M; Lavitrano ML; de Grazia U; Gellera C; Ruggieri S
Clin Genet; 2000 Jul; 58(1):50-6. PubMed ID: 10945661
[TBL] [Abstract][Full Text] [Related]
10. Severity of cognitive impairment in juvenile and late-onset Huntington disease.
Gómez-Tortosa E; del Barrio A; García Ruiz PJ; Pernaute RS; Benítez J; Barroso A; Jiménez FJ; García Yébenes J
Arch Neurol; 1998 Jun; 55(6):835-43. PubMed ID: 9626775
[TBL] [Abstract][Full Text] [Related]
11. Huntington disease and Huntington disease-like in a case series from Brazil.
Castilhos RM; Souza AF; Furtado GV; Gheno TC; Silva AL; Vargas FR; Lima MA; Barsottini O; Pedroso JL; Godeiro C; Salarini D; Pereira ET; Lin K; Toralles MB; Saute JA; Rieder CR; Quintas M; Sequeiros J; Alonso I; Saraiva-Pereira ML; Jardim LB
Clin Genet; 2014 Oct; 86(4):373-7. PubMed ID: 24102565
[TBL] [Abstract][Full Text] [Related]
12. The Clinical Features and Progression of Late-Onset Versus Younger-Onset in an Adult Cohort of Huntington's Disease Patients.
Anil M; Mason SL; Barker RA
J Huntingtons Dis; 2020; 9(3):275-282. PubMed ID: 32675419
[TBL] [Abstract][Full Text] [Related]
13. Evaluating motor progression of juvenile-onset Huntington's Disease: An Enroll-HD analysis.
Nopoulos S; Reasoner EE; Ogilvie AC; Killoran A; Schultz JL
Parkinsonism Relat Disord; 2024 Feb; 119():105954. PubMed ID: 38142629
[TBL] [Abstract][Full Text] [Related]
14. The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington's disease patients with predominant chorea.
Maglione V; Cannella M; Martino T; De Blasi A; Frati L; Squitieri F
Neurosci Lett; 2006 Jan; 393(1):27-30. PubMed ID: 16221531
[TBL] [Abstract][Full Text] [Related]
15. What do we know about Late Onset Huntington's Disease?
Chaganti SS; McCusker EA; Loy CT
J Huntingtons Dis; 2017; 6(2):95-103. PubMed ID: 28671137
[TBL] [Abstract][Full Text] [Related]
16. Early-Motor Phenotype Relates to Neuropsychiatric and Cognitive Disorders in Huntington's Disease.
Julayanont P; Heilman KM; McFarland NR
Mov Disord; 2020 May; 35(5):781-788. PubMed ID: 31922295
[TBL] [Abstract][Full Text] [Related]
17. Age, CAG repeat length, and clinical progression in Huntington's disease.
Rosenblatt A; Kumar BV; Mo A; Welsh CS; Margolis RL; Ross CA
Mov Disord; 2012 Feb; 27(2):272-6. PubMed ID: 22173986
[TBL] [Abstract][Full Text] [Related]
18. Onset and pre-onset studies to define the Huntington's disease natural history.
Squitieri F; Cannella M; Giallonardo P; Maglione V; Mariotti C; Hayden MR
Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):233-8. PubMed ID: 11719256
[TBL] [Abstract][Full Text] [Related]
19. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
[TBL] [Abstract][Full Text] [Related]
20. Genetic screening for Huntington's disease in Chinese patients with involuntary movements.
Shan DE; Soong BW; Yeh SI; Cheng CH; Wu ZA
Clin Neurol Neurosurg; 1997 Dec; 99(4):244-7. PubMed ID: 9491297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
